Greenline Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$67.7K 287
2025
Q4
$67.7K Buy
+100
New +$68.1K 0.07% 170

Other funds holding IDXX

Greenline Wealth Management's IDXX Position: Q1 2026 in Review

Greenline Wealth Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 100 shares — an estimated $67.7K sold.

Greenline Wealth Management first reported a position in IDXX in Q4 2025 and held it in 1 quarter. The position peaked at $67.7K in Q4 2025. 1,318 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Greenline Wealth Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Greenline Wealth Management sold 100 Idexx Laboratories shares in Q1 2026, an estimated $67.7K.
  • Greenline Wealth Management first reported a position in Idexx Laboratories in Q4 2025 and held it in 1 quarter.
  • Greenline Wealth Management's Idexx Laboratories position peaked at $67.7K in Q4 2025.
  • 1,318 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Greenline Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.